A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06603077 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

253

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: AVTX-009 Regimen 1
DRUG: AVTX-009 Regimen 2
DRUG: Placebo

Sponsor

Avalo Therapeutics, Inc.